Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DULOXETINE DELAYED-RELEASE CAPSULES, safely and effectively. See full prescribing information for DULOXETINE DELAYED-RELEASE CAPSULES. DULOXETINE delayed-release capsules, for oral use Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
Duloxetine delayed-release capsules USP are indicated for the treatment of: • Major depressive disorder in adults • Generalized anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults • Chronic musculoskeletal pain in adults Additional pediatric use information is approved for Eli Lilly and Company, Inc.’s CYMBALTA (duloxetine) delayed-release capsules. However, due to Eli Lilly and Company Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
- generic_name
- duloxetine
- product_names
- Duloxetine
- ndc
- 47335-381, 47335-382, 47335-383, 47335-381-83, 47335-381-86, 47335-381-88, 47335-381-08, 47335-381-18, 47335-381-61, 47335-382-83, 47335-382-81, 47335-382-88, 47335-382-08, 47335-382-18, 47335-382-61, 47335-383-83, 47335-383-88, 47335-383-08, 47335-383-18, 47335-383-61
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en